Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals (2008)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; BERNIK, MARCIA MARTINS SILVEIRA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- Subjects: POLIMORFISMO; FARMACOGENÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical Chemistry and Laboratory Medicine
- ISSN: 1434-6621
- Volume/Número/Paginação/Ano: v. 46 , n. S1, supl. 1, p. S571 res. W202, 2008
- Conference titles: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab
-
ABNT
CERDA, Alvaro et al. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 29 dez. 2025. , 2008 -
APA
Cerda, A., Arazi, S. S., Genvigir, F. D. V., Hirata, M. H., Dórea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2008). Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Cerda A, Arazi SS, Genvigir FDV, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S571 res. W202.[citado 2025 dez. 29 ] -
Vancouver
Cerda A, Arazi SS, Genvigir FDV, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S571 res. W202.[citado 2025 dez. 29 ] - CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin
- Atorvastatin down-regulates ABCA1 gene expression in peripheral blood mononuclear cells of Brazilian hyper-cholesterolemic patients
- Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients
- Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes
- Polimorfismos no receptor scavenger classe B tipo I e sua relação com perfil sérico e resposta a atorvastatina em indivíduos brasileiros
- Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response
- Estudo da expressão gênica e polimorfismos da CYP3A5 em indivíduos hipercolesterolêmicos tratados com atorvastatina
- Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia
- mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy
- Resposta hipolipemiante à atorvastatina é modificada pelo polimorfismo do gene da CYP3A5
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
